Citation Impact
Citing Papers
In Vivo Detection of EGFRvIII in Glioblastoma via Perfusion Magnetic Resonance Imaging Signature Consistent with Deep Peritumoral Infiltration: The ϕ -Index
2017
Effect of Salvia officinalis Hydroalcoholic Extract on Vincristine-induced Neuropathy in Mice
2011
Pharmacological properties of Salvia officinalis and its components
2017 Standout
The Pharmacological Potential of Rutin
2016 Standout
Advancing The Cancer Genome Atlas glioma MRI collections with expert segmentation labels and radiomic features
2017
Cancer treatment and survivorship statistics, 2022
2022 Standout
Exercise Intervention Studies in Patients with Peripheral Neuropathy: A Systematic Review
2014
The flavonoid 6-methoxyflavone allays cisplatin-induced neuropathic allodynia and hypoalgesia
2017
MultiResUNet : Rethinking the U-Net architecture for multimodal biomedical image segmentation
2019 Standout
Glioblastoma and Other Malignant Gliomas
2013 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Medical management of brain tumors and the sequelae of treatment
2014
The Challenges of Colorectal Cancer Survivorship
2009
Radiogenomics of Glioblastoma: Machine Learning–based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features
2016
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
2014 Standout
Preparing Medical Imaging Data for Machine Learning
2020 Standout
Combinations of Bevacizumab With Cancer Immunotherapy
2018
Federated learning in medicine: facilitating multi-institutional collaborations without sharing patient data
2020 Standout
Measures of preoperative anxiety
2019 Standout
Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature
2015
Metabolic reprogramming in macrophage responses
2021
Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable
2019 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy
2013
Management of glioblastoma: State of the art and future directions
2020 Standout
The Antioxidant Effects of the Flavonoids Rutin and Quercetin Inhibit Oxaliplatin-Induced Chronic Painful Peripheral Neuropathy
2013
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
2021 Standout
Association of pre-operative depressive and anxiety symptoms with five-year survival of glioma and meningioma patients: a prospective cohort study
2017
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 Blockade
2017 StandoutNobel
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout
Healthcare Costs and Workloss Burden of Patients with Chemotherapy-Associated Peripheral Neuropathy in Breast, Ovarian, Head and Neck, and Nonsmall Cell Lung Cancer
2012
Works of Thomas Kaley being referenced
Atypical and anaplastic meningiomas treated with bevacizumab
2012
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
2012
Therapy of chemotherapy‐induced peripheral neuropathy
2009
Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma
2019
T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status
2015
Whole-brain radiotherapy in patients with brain metastases from melanoma
2014
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review
2014
Phase II study of pembrolizumab or pembrolizumab plus bevacizumab for recurrent glioblastoma (rGBM) patients.
2018